Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease (NCT06721234) | Clinical Trial Compass
RecruitingNot Applicable
Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease
Egypt100 participantsStarted 2024-12-02
Plain-language summary
Evaluation of femoral vein wall thickness and inflammatory indices in patients with Behcet disease and assessment of their relation to the disease activity and related some clinical manifestations
Who can participate
Age range
19 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients fulfill the International Criteria for Behcet's Disease (ICBD)
* Age above 18 years old
* Patients cooperative and can answer questions
* Patients who are able and willing to give informed consent
Exclusion Criteria:
* Other rheumatological and vascular diseases
* Patients with abnormal hepatic or renal function tests , hyperlipidemia and impaired coagulation tests
* Patients with hypertension , diabetes mellitus , malignant and active infectious diseases
* Patients who are using aspirin and other platelet active drygs during the previous 6 months
* patients who are not able and willing to give written consent
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this study is measuring femoral vein wall thickness in people with Behçet's disease, can you explain what that measurement might tell us about my vascular health and whether it's something we should already be monitoring in my care?
2This trial also looks at inflammatory markers alongside vein wall changes — are my current inflammation levels the kind that would be relevant to what this study is trying to understand?
3Since this is listed as 'Phase NA,' which suggests it's an observational or measurement study rather than a treatment trial, can you help me understand what participating would actually involve for me — like tests, visits, or procedures?
4Would joining this study give me access to any vein imaging or blood work results that could be useful for managing my Behçet's disease, or is the data primarily used for research purposes?
5Given that this is a study focused on measurement and not on testing a new treatment, is there any standard-of-care monitoring or treatment path you'd recommend I pursue at the same time, rather than instead of this?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.